WSL017
WSL017 is a cytochrome bd oxidase inhibitor with antibacterial activity against Mycobacterium tuberculosis. WSL017 can be used for the research of tuberculosis.
For research use only. We do not sell to patients.
- Formula: C17H19NOS
- Molecular Weight:285.40
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
WSL017 (0.001-100 µM) competitively inhibits Mycobacterium tuberculosis cytochrome bd (Mtbd) in proteoliposomes with an IC50 of 1.4 µM by binding to the quinol-binding site[1].
WSL017 (0.001-100 µM) competitively inhibits Escherichia coli cytochrome bd (Ecbd) in proteoliposomes with an IC50 of 1.7 µM by binding to the quinol-binding site[1].
WSL017 (3 µM) does not inhibit Caldalkalibacillus thermarum type 2 NADH dehydrogenase (NDH2) activity, confirming its specific action on cytochrome bd oxidases[1].
WSL017 (100 µM) binds to the quinol oxidation site of dimeric Escherichia coli cytochrome bd (Ecbd) via hydrophobic interactions, stabilizing the Q-loop in a closed state to inhibit enzyme activity[1].
WSL017 (25 µM; 7 days) significantly impairs the growth of Mycobacterium tuberculosis H37ra cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Mycobacterium tuberculosis H37ra cells
-
Concentration:25 µM
-
Incubation Time:7 days
-
Result:Reduced growth to approximately 50% relative to control.
Significantly impaired the growth of Mycobacterium tuberculosis H37ra cells.
Chemical Information
-
Molecular Weight 285.40
-
Formula C17H19NOS
-
SMILES
CCC(NC1=CC=C(SC2=CC(C)=CC=C2C)C=C1)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)